OM:CAMX
OM:CAMXPharmaceuticals

How FDA Review of Oclaiz Could Shape Camurus’ (OM:CAMX) Long-Term Endocrinology Strategy

Camurus AB (publ) recently announced that the U.S. FDA has accepted for review its resubmitted New Drug Application for Oclaiz (CAM2029), an extended-release octreotide injection for acromegaly, with a PDUFA target action date set for 10 June 2026. This acceptance helps clear a prior hurdle tied to third-party manufacturing observations and follows earlier EU and UK approvals and launch of the same product, marketed there as Oczyesa. We will now examine how FDA acceptance of the Oclaiz...
OM:NOBI
OM:NOBIConsumer Durables

Assessing Nobia (OM:NOBI) Valuation After UK Exit Plan And SEK 1.5b Rights Issue

Why Nobia’s rights issue and UK exit matter for shareholders Nobia (OM:NOBI) is overhauling its business by selling its UK operations, refocusing on Nordic markets, and raising approximately SEK 1.5b through a rights issue, together with new loan agreements and planned capital structure changes. See our latest analysis for Nobia. The rights issue, UK exit and refinancing have come against a weak share price backdrop, with a 7 day share price return of 27.12% decline and a 5 year total...
OM:TRUE B
OM:TRUE BSoftware

A Look At Truecaller (OM:TRUE B) Valuation After Fresh Share Buybacks And AGM Timing

Truecaller (OM:TRUE B) has completed another round of share repurchases, taking treasury holdings to 5.02%, with the buyback programme timed ahead of the company’s 2026 Annual General Meeting. See our latest analysis for Truecaller. Despite the latest buybacks, the share price has come under pressure, with a 1 day share price return of a 2.96% decline, a 7 day share price return of a 9.94% decline and a 90 day share price return of a 57.88% decline. The 1 year total shareholder return of a...
OM:BETS B
OM:BETS BHospitality

Assessing Betsson (OM:BETS B) Valuation After Weaker Q4 2025 Guidance And Share Price Drop

Why Betsson’s latest guidance has grabbed investor attention Betsson (OM:BETS B) has come under pressure after preliminary Q4 2025 guidance pointed to softer results, with revenue expected at €304 million and operating income at €53 million, both below the prior year. The update, combined with weaker sportsbook and B2B trends, triggered a sharp share price reaction. This has left many investors reassessing how the business mix, regional performance, and ongoing product investments could shape...
OM:ERIC B
OM:ERIC BCommunications

A Look At Ericsson’s (OM:ERIC B) Valuation After Announced Staff Reductions In Sweden

Telefonaktiebolaget LM Ericsson (OM:ERIC B) has drawn fresh investor attention after announcing proposed staff reductions affecting about 1,600 positions in Sweden, as part of wider cost focused initiatives across the group. See our latest analysis for Telefonaktiebolaget LM Ericsson. At a share price of SEK 87.52, Ericsson has seen a 1-year total shareholder return decline of 4.82%, although the 3-year total shareholder return of 68.28% suggests longer term momentum has been stronger than...
OM:NOBI
OM:NOBIConsumer Durables

Why Nobia (OM:NOBI) Is Down 19.8% After Announcing SEK 1.50bn Rights Issue And New Credit Facilities - And What's Next

Nobia AB (publ) has announced plans for a SEK 1.50 billion rights issue alongside an amended and extended SEK 2.50 billion revolving credit facility and a SEK 1.50 billion bridge term facility, supported by proposed changes to its articles of association to allow share capital reduction without redeeming shares. Together, these financing and governance measures point to a significant balance sheet reshaping that could influence Nobia’s financial flexibility and future capital structure...
OM:SKF B
OM:SKF BMachinery

European Dividend Stocks To Enhance Your Portfolio

As the European markets continue to show optimism with indices like the STOXX Europe 600 Index ending higher amid a strengthening eurozone economy, investors are increasingly drawn to dividend stocks as a means of enhancing portfolio stability. In this context, selecting stocks that offer reliable dividends can be particularly appealing, providing both income and potential growth in an environment characterized by favorable interest rates and improving industrial production.